Semler Scientific, Inc. (NASDAQ:SMLR) Short Interest Up 20.1% in March

Semler Scientific, Inc. (NASDAQ:SMLR) was the recipient of a significant growth in short interest in March. As of March 31st, there was short interest totalling 1,790,000 shares, a growth of 20.1% from the March 15th total of 1,490,000 shares. Based on an average trading volume of 407,200 shares, the days-to-cover ratio is presently 4.4 days. Approximately 23.0% of the shares of the company are sold short.

Semler Scientific Stock Down 8.2 %

NASDAQ:SMLR opened at $29.83 on Tuesday. Semler Scientific has a 12-month low of $20.88 and a 12-month high of $81.56. The firm has a market capitalization of $286.28 million, a price-to-earnings ratio of 6.08 and a beta of 1.29. The stock’s 50 day moving average price is $38.32 and its two-hundred day moving average price is $45.99.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.20 by $3.21. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%. The business had revenue of $12.41 million for the quarter.

Hedge Funds Weigh In On Semler Scientific

Several large investors have recently modified their holdings of SMLR. BNP Paribas Financial Markets bought a new stake in shares of Semler Scientific during the fourth quarter worth approximately $30,000. Jones Financial Companies Lllp bought a new stake in shares of Semler Scientific in the fourth quarter valued at about $34,000. Larson Financial Group LLC acquired a new position in shares of Semler Scientific in the fourth quarter valued at about $38,000. NewEdge Advisors LLC increased its position in Semler Scientific by 318.3% during the fourth quarter. NewEdge Advisors LLC now owns 732 shares of the company’s stock worth $40,000 after acquiring an additional 557 shares during the period. Finally, IFP Advisors Inc acquired a new stake in Semler Scientific in the 4th quarter worth about $54,000. 49.37% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Lake Street Capital boosted their price objective on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a research note on Friday, January 24th.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.